Aetna is in the process of transforming from a traditional health insurance company to becoming a healthcare-focused company, in part by emphasizing value-based reimbursement and social determinants of health, said Harold L. Paz, MD, MS, executive vice president and chief medical officer at Aetna.
Aetna is in the process of transforming from a traditional health insurance company to becoming a healthcare-focused company, in part by emphasizing value-based reimbursement and social determinants of health, said Harold L. Paz, MD, MS, executive vice president and chief medical officer at Aetna.
Transition (slightly modified)
What challenges do you foresee as Aetna continues to move toward value-based care?
For Aetna I would say the opportunity, and with that the challenge, is how we transform this company from being a traditional health insurance company to becoming a healthcare company. And that’s really our focus in our Vision 2020 strategic plan. We believe that in the future the emphasis will be on value-based reimbursement models and the need to really coordinate care for individuals that bring in the social determinants of health and the multiple determinants of health to increase the number of healthy days that each individual has. That’s not just physical health, but it’s mental health, and it’s social health.
To do that effectively, it really requires creating these innovative partnerships that begin in the home and are based in the community. That is a massive transformation for Aetna, but it is one that we’re fully committed to. It is in our vision and that’s what our entire strategic plan is predicated on.
IgE Mediation in Pediatric Atopic Dermatitis, Concurrent Immune Disorders: Amy Paller, MD
August 4th 2025Amy Paller, MD, pediatric dermatologist and clinical researcher at Northwestern Medicine's Feinberg School of Medicine, discussed the potential impact of reducing immunoglobulin E (IgE) levels in pediatric patients with atopic dermatitis.
Read More
It Take a Village in Cancer Care: A Q&A With David Nguyen, MD
July 23rd 2025David Nguyen, MD, medical oncologist with Tufts Medicine and Lowell General Hospital, discusses the evolving landscape of advanced cancer treatments like chimeric antigen receptor T-cell therapy and bispecific antibodies
Read More
Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025
July 18th 2025These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.
Read More